Essential Biotechnology in the news: News From the Heartland. The Journal of the Heartland Angels

“A protein, CRR9, serves as a nexus for tumor cell survival. It’s located on the cell surface, making it an accessible drug target. By developing antibodies to the CRR9 protein, Essential Biotechnology has devised a method to kill therapy-resistant tumors.” – Jayson Kurfis

See the article here.

http://news.heartlandangels.com/wp-content/uploads/2016/05/NEWS-FROM-HEARTLAND-May-2016-v2.pdf

Cancer-Treatment-from-MS-Office